Peer-Based Knowledge Validation: A Hurdle to the Flow of Academic Science to Inventors

Despite the academic norm of openness, practitioners have repeatedly complained that promising academic discoveries are not being exploited by inventors. I argue that this disconnect might be in part explained by considering a hurdle to knowledge dissemination that has received little attention to date. The work of academic researchers is validated by their peers rather than by inventors, leading to ambiguity about the value of scientific knowledge for technology development. I test this proposition by examining inventors’ propensity to exploit scientific knowledge published by academic and industrial scientists in the case of simultaneous discoveries. Analysis of inventors’ referencing patterns to a set of “paper twins” indicates that inventors are less likely to exploit a discovery if it is published by an academic institution. Taken together, the results suggest that the peer-based knowledge validation process in academia creates uncertainty about the reliability and relevance of academic science as a map for technology development.

[1]  Seongwuk Moon,et al.  How Does the Management of Research Impact the Disclosure of Knowledge? Evidence from Scientific Publications and Patenting Behavior , 2008 .

[2]  Nicola Lacetera,et al.  Di¤erent Missions and Commitment Power in R&d Organization: Theory and Evidence on Industry-university Alliances , 2022 .

[3]  Susan E. Cozzens,et al.  Social Control and Multiple Discovery in Science: The Opiate Receptor Case. , 1989 .

[4]  Philippe Aghion,et al.  Academic Freedom, Private-Sector Focus, and the Process of Innovation , 2005 .

[5]  Paula E. Stephan,et al.  A multidimensional view of industrial and academic science , 2011 .

[6]  P. David,et al.  Toward a new economics of science , 1994 .

[7]  D. Dougherty Interpretive Barriers to Successful Product Innovation in Large Firms , 1992 .

[8]  Diego Piccioli,et al.  Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells , 2002, The Journal of experimental medicine.

[9]  S. Woolgar,et al.  The Manufacture of Knowledge: an Essay on the Constructivist and Contextual Nature of Science , 1982 .

[10]  M. Callon Some Elements of a Sociology of Translation: Domestication of the Scallops and the Fishermen of St Brieuc Bay , 1984 .

[11]  K. Knorr-Cetina The Manufacture of Knowledge: an Essay on the Constructivist and Contextual Nature of Science , 1985 .

[12]  L. Zirulia,et al.  The Economics of Scientific Misconduct , 2008 .

[13]  A. Panchula,et al.  Giant tunnelling magnetoresistance at room temperature with MgO (100) tunnel barriers , 2004, Nature materials.

[14]  M. Heller,et al.  Can Patents Deter Innovation? The Anticommons in Biomedical Research , 1998, Science.

[15]  C. Haeussler Information-Sharing in Academia and the Industry: A Comparative Study , 2010 .

[16]  D. Butler Translational research: Crossing the valley of death , 2008, Nature.

[17]  V. Bush Science, the Endless Frontier , 1999, Science, the Endless Frontier.

[18]  Z. Griliches Patent Statistics as Economic Indicators: a Survey , 1990 .

[19]  M. Tushman,et al.  Boundary Spanning Individuals: Their Role in Information Transfer and Their Antecedents , 1981 .

[20]  Wiebe E. Bijker,et al.  Science in action : how to follow scientists and engineers through society , 1989 .

[21]  John P. Walsh,et al.  Academic Entrepreneurship and Exchange of Scientific Resources , 2012 .

[22]  Scott Shane,et al.  The Halo Effect and Technology Licensing: The Influence of Institutional Prestige on the Licensing of University Inventions , 2003, Manag. Sci..

[23]  R. Nelson The Role of Knowledge in R&D Efficiency , 1982 .

[24]  Lev Osherovich,et al.  Hedging against academic risk , 2011 .

[25]  J. Blenis,et al.  FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. , 2000, Immunity.

[26]  W. Ocasio TOWARDS AN ATTENTION-BASED VIEW OF THE FIRM , 1997 .

[27]  Fiona Murray,et al.  Exploring the Foundations of Cumulative Innovation: Implications for Organization Science , 2007, Organ. Sci..

[28]  D. E. Stokes Pasteur's Quadrant: Basic Science and Technological Innovation , 1997 .

[29]  B. Latour,et al.  Laboratory Life: The Construction of Scientific Facts , 1979 .

[30]  Scott Stern,et al.  Climbing Atop the Shoulders of Giants: The Impact of Institutions on Cumulative Research , 2006, American Economic Review.

[31]  Jacob Schmookler,et al.  Invention and Economic Growth , 1967 .

[32]  Bruce Alberts Is the Frontier Really Endless? , 2010, Science.

[33]  M. Spence Competitive and optimal responses to signals: An analysis of efficiency and distribution , 1974 .

[34]  Michelle Gittelman,et al.  Does Good Science Lead to Valuable Knowledge? Biotechnology Firms and the Evolutionary Logic of Citation Patterns , 2003, Manag. Sci..

[35]  O. Sorenson,et al.  Science and the Diffusion of Knowledge , 2001 .

[36]  S. Hilgartner,et al.  Data withholding in academic genetics: evidence from a national survey. , 2002, JAMA.

[37]  O. Sorenson,et al.  Science as a Map in Technological Search , 2000 .

[38]  Fiona E. Murray The Oncomouse That Roared: Hybrid Exchange Strategies as a Source of Distinction at the Boundary of Overlapping Institutions1 , 2010, American Journal of Sociology.

[39]  Paula E. Stephan The Economics of Science , 1996 .

[40]  Michelle Gittelman,et al.  Does Geography Matter for Science-Based Firms? Epistemic Communities and the Geography of Research and Patenting in Biotechnology , 2007, Organ. Sci..

[41]  Giovanni Melioli,et al.  Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells , 2002, The Journal of experimental medicine.

[42]  Wesley M. Cohen,et al.  Where excludability matters: Material versus intellectual property in academic biomedical research , 2007 .

[43]  R. Nelson The market economy, and the scientific commons , 2004 .

[44]  Karim R. Lakhani,et al.  Looking Across and Looking Beyond the Knowledge Frontier: Intellectual Distance, Novelty, and Resource Allocation in Science , 2016, Manag. Sci..

[45]  Heidi L. Williams Intellectual Property Rights and Innovation: Evidence from the Human Genome , 2010, Journal of Political Economy.

[46]  David C. Mowery,et al.  Does University Licensing Facilitate or Restrict the Flow of Knowledge and Research Inputs Among Scientists , 2014 .

[47]  James A. Evans Industry Induces Academic Science to Know Less about More1 , 2010, American Journal of Sociology.

[48]  Walter W. Powell,et al.  Knowledge Networks as Channels and Conduits: The Effects of Spillovers in the Boston Biotechnology Community , 2004, Organ. Sci..

[49]  B. Latour Science in action : how to follow scientists and engineers through society , 1989 .

[50]  Nathan Rosenberg,et al.  Incentives and Focus in University and Industrial Research: The Case of Synthetic Insulin , 1995 .

[51]  M. Trajtenberg,et al.  Universities as a Source of Commercial Technology: A Detailed Analysis of University Patenting, 19651988 , 1995, Review of Economics and Statistics.

[52]  Suzanne K. Linder,et al.  A Survey on Data Reproducibility in Cancer Research Provides Insights into Our Limited Ability to Translate Findings from the Laboratory to the Clinic , 2013, PloS one.

[53]  Gary Chamberlain,et al.  Analysis of Covariance with Qualitative Data , 1979 .

[54]  Pierre Azoulay,et al.  Do Pharmaceutical Sales Respond to Scientific Evidence , 2002 .

[55]  Fiona Murray,et al.  Governing knowledge in the scientific community: Exploring the role of retractions in biomedicine , 2012 .

[56]  Andrew J. Nelson How to Share "A Really Good Secret": Managing Sharing/Secrecy Tensions Around Scientific Knowledge Disclosure , 2016, Organ. Sci..

[57]  Owen-SmithJason,et al.  Knowledge Networks as Channels and Conduits , 2004 .

[58]  M. Heller,et al.  Can Patents Deter Innovation , 1998 .

[59]  D. Lawrence,et al.  Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. , 2000, Immunity.

[60]  S. Winter,et al.  An evolutionary theory of economic change , 1983 .

[61]  M. Gittelman,et al.  Patent Citations as a Measure of Knowledge Flows: The Influence of Examiner Citations , 2006, The Review of Economics and Statistics.

[62]  Merrill Goozner,et al.  The $800 Million Pill: The Truth behind the Cost of New Drugs , 2004 .

[63]  Mark A. Lemley,et al.  Examiner Characteristics and Patent Office Outcomes , 2009 .

[64]  Joel Mokyr,et al.  The Gifts of Athena: Historical Origins of the Knowledge Economy , 2002 .

[65]  Jason Owen-Smith Managing Laboratory Work through Skepticism: Processes of Evaluation and Control , 2001, American Sociological Review.

[66]  Peeter W. J. Verlegh,et al.  A review and meta-analysis of country-of-origin research , 1999 .

[67]  I. Cockburn,et al.  Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery , 2003 .

[68]  M. Rosenblatt,et al.  An incentive-based approach for improving data reproducibility , 2016, Science Translational Medicine.

[69]  Benjamin F. Jones The Burden of Knowledge and the &Apos;Death of the Renaissance Man&Apos;: Is Innovation Getting Harder? , 2005 .